| Innate immune cell death in neuroinflammation and Alzheimer’s disease Y Rajesh, TD Kanneganti Cells 11 (12), 1885, 2022 | 133 | 2022 |
| Insights into molecular therapy of glioma: current challenges and next generation blueprint Y Rajesh, I Pal, P Banik, S Chakraborty, SA Borkar, G Dey, A Mukherjee, ... Acta pharmacologica sinica 38 (5), 591-613, 2017 | 126 | 2017 |
| Multi-nucleated cells use ROS to induce breast cancer chemo-resistance in vitro and in vivo A Parekh, S Das, S Parida, CK Das, D Dutta, SK Mallick, PH Wu, ... Oncogene 37 (33), 4546-4561, 2018 | 84 | 2018 |
| EXTRACTION, PHYTOCHEMICAL SCREENING AND IN-VITRO EVALUATION OF ANTI-OXIDANT PROPERTIES OF COMMICARPUS CHINESIS (AQUEOUS LEAF EXTRACT) M BOXI, Y RAJESH, VR KUMAR*, B PRAVEEN, K MANGAMMA International Journal of Pharma and Bio Sciences 1 (4), 2010 | 78* | 2010 |
| Gold nanorod embedded reduction responsive block copolymer micelle-triggered drug delivery combined with photothermal ablation for targeted cancer therapy S Parida, C Maiti, Y Rajesh, KK Dey, I Pal, A Parekh, R Patra, D Dhara, ... Biochimica et Biophysica Acta (BBA)-General Subjects 1861 (1), 3039-3052, 2017 | 74 | 2017 |
| Association of adipose tissue and adipokines with development of obesity-induced liver cancer Y Rajesh, D Sarkar International Journal of Molecular Sciences 22 (4), 2163, 2021 | 57 | 2021 |
| Glioma progression through the prism of heat shock protein mediated extracellular matrix remodeling and epithelial to mesenchymal transition Y Rajesh, A Biswas, M Mandal Experimental cell research 359 (2), 299-311, 2017 | 50 | 2017 |
| Photocaging of single and dual (similar or different) carboxylic and amino acids by acetyl carbazole and its application as dual drug delivery in cancer therapy Y Venkatesh, Y Rajesh, S Karthik, AC Chetan, M Mandal, A Jana, ... The Journal of Organic Chemistry 81 (22), 11168-11175, 2016 | 47 | 2016 |
| S100A7 has an oncogenic role in oral squamous cell carcinoma by activating p38/MAPK and RAB2A signaling pathway KK Dey, R Bharti, G Dey, I Pal, Y Rajesh, S Chavan, S Das, CK Das, ... Cancer gene therapy 23 (11), 382-391, 2016 | 43 | 2016 |
| Lumefantrine, an antimalarial drug, reverses radiation and temozolomide resistance in glioblastoma Y Rajesh, A Biswas, U Kumar, I Banerjee, S Das, S Maji, SK Das, ... Proceedings of the National Academy of Sciences 117 (22), 12324-12331, 2020 | 41 | 2020 |
| Therapeutic implication of ‘Iturin A’for targeting MD-2/TLR4 complex to overcome angiogenesis and invasion G Dey, R Bharti, PK Ojha, I Pal, Y Rajesh, I Banerjee, P Banik, S Parida, ... Cellular signalling 35, 24-36, 2017 | 40 | 2017 |
| Prevention of epithelial to mesenchymal transition in colorectal carcinoma by regulation of the E-cadherin-β-catenin-vinculin axis I Pal, Y Rajesh, P Banik, G Dey, KK Dey, R Bharti, D Naskar, ... Cancer letters 452, 254-263, 2019 | 39 | 2019 |
| Delineation of crosstalk between HSP27 and MMP-2/MMP-9: A synergistic therapeutic avenue for glioblastoma management Y Rajesh, A Banerjee, I Pal, A Biswas, S Das, KK Dey, N Kapoor, ... Biochimica et Biophysica Acta (BBA)-General Subjects 1863 (7), 1196-1209, 2019 | 35 | 2019 |
| Immune regulator IRF1 contributes to ZBP1-, AIM2-, RIPK1-, and NLRP12-PANoptosome activation and inflammatory cell death (PANoptosis) BR Sharma, R Karki, Y Rajesh, TD Kanneganti Journal of Biological Chemistry 299 (9), 2023 | 34 | 2023 |
| Copper (II)-sulfonamide Schiff base complexes: Structure, biological activity and theoretical interpretation S Mondal, TK Mondal, Y Rajesh, M Mandal, C Sinha Polyhedron 151, 344-354, 2018 | 34 | 2018 |
| Molecular Mechanisms Regulating Obesity-Associated Hepatocellular Carcinoma Y Rajesh, D Sarkar Cancers 12 (5), 1290, 2020 | 31 | 2020 |
| Cascade photocaging of diazeniumdiolate: a novel strategy for one and two photon triggered uncaging with real time reporting KK Behara, Y Rajesh, Y Venkatesh, BR Pinninti, M Mandal, NDP Singh Chemical Communications 53 (68), 9470-9473, 2017 | 30 | 2017 |
| Targeting NFE2L2, a transcription factor upstream of MMP-2: a potential therapeutic strategy for temozolomide resistant glioblastoma Y Rajesh, A Biswas, U Kumar, S Das, I Banerjee, P Banik, R Bharti, ... Biochemical Pharmacology 164, 1-16, 2019 | 29 | 2019 |
| ETV6 gene aberrations in non-haematological malignancies: A review highlighting ETV6 associated fusion genes in solid tumors A Biswas, Y Rajesh, P Mitra, M Mandal Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1874 (1), 188389, 2020 | 25 | 2020 |
| Transcriptional regulation of HSPB1 by Friend leukemia integration-1 factor modulates radiation and temozolomide resistance in glioblastoma Y Rajesh, A Biswas, P Banik, I Pal, S Das, S A Borkar, H Sardana, A Saha, ... Oncotarget 2020 (11), 1097-1108, 2020 | 22 | 2020 |
